Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors

Biotechnology and Bioengineering

Volumn 77, Issue 6, 2002, Pages 685-692

  Ozuer, Ali ^a   Wechuck, James B ^a   Goins, William F ^b   Wolfe, Darren ^b   Glorioso, Joseph C ^b   Ataai, Mohammad M ^a  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Gene therapy; Herpes simplex virus type 1; Viral vector production

Indexed keywords

BIOREACTORS; CELL CULTURE; DNA; OPTIMIZATION; TISSUE;

GENE THERAPY;

GENETIC ENGINEERING;

DNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BIOREACTOR; CELL LINE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOTOXICITY; DNA VECTOR; GENE EXPRESSION; GENE REPLICATION; GENE TARGETING; GENE THERAPY; HERPES SIMPLEX VIRUS 1; NONHUMAN; TISSUE CULTURE; VIRAL GENE DELIVERY SYSTEM; VIRUS CULTURE;

BIOREACTORS; CELL LINE; CULTURE MEDIA; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0037139751     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.10162     Document Type: Article

References (34)

1. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle
2. Isolation and characterization of deletion mutants of Herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4
3. Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175
4. Progress in the development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis
5. Herpes simplex virus vectors for gene transfer to the nervous system
6. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglia neurons from peroxide toxicity
7. RNA complementary to herpes simplex virus type 1 ICP0 gene demonstrated in neurons of human trigeminal ganglia
8. Viral DNA synthesis is required for efficient expression of specific herpes simplex virus type 1 mRNA
9. Regulation of herpes simplex virus macromolecular synthesis I. Cascade regulation of the synthesis of three groups of viral proteins
10. Gene transfer to muscle using herpes simplex virus-based vectors
11. Cytotoxicity of a replication-defective mutant herpes simplex virus type 1
12. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector
13. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders
14. Improved methods of retroviral vector transduction and production for gene therapy
15. Rapid method for construction of recombinant HSV gene transfer vectors
16. Development of herpes simplex virus replication defective multigene vectors for combination gene therapy applications
17. Deletion of multiple immediate early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons
18. Herpes simplex virus virion host shutoff function
19. Identification of the herpes simplex virus DNA sequences present in six herpes simplex virus thymidine kinase-transformed mouse cell lines
20. Replication-defective HSV vectors for gene transfer in vivo
21. Activation of herpes simplex virus 1 γ2 genes by viral DNA replication
22. Physical state of the latent herpes simplex virus genome in a mouse model system: Evidence suggesting an episomal state
23. Control of mRNA stability by the virion host shutoff function of herpes simplex virus
24. Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of α (immediate early) viral polypeptides
25. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture
26. Functional interaction between herpes simplex virus immediate-early proteins during infection: Gene expression as a consequence of ICP27 and different domains of ICP4
27. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27
28. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins
29. Gene transfer to the nervous system using HSV vectors
30. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection
31. RNA complementary to a herpesviruses α gene mRNA is prominent in latently infected neurons
32. Engineering herpes simplex virus vectors for CNS applications
33. Systemic delivery of nerve growth factor following herpesvirus gene transfer
34. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22